Is it flu or coronavirus? Iceni Diagnostics' device will tell you in 15 mins
A new test being developed by Iceni Diagnostics promises a quick way to distinguish between the two diseases
A new test being developed by Iceni Diagnostics promises a quick way to distinguish between the two diseases
Promega automated sample preparation solution added to CDC COVID-19 test protocol
Interim data shows strong antibody and T-cell responses in all evaluated participants
Company also receives new FDA emergency use authorizations for use of self-collection molecular diagnostic kit on the Hologic and Roche platforms
xMAP SARS-CoV-2 Multi-Antigen IgG Assay is enabled by xMAP Technology, the gold standard for multiplexing serologic testing
Cambridge researchers have shown how rapid genome sequencing of virus samples and enhanced testing of hospital staff can help to identify clusters of healthcare-associated COVID-19 infections
The bridging assay aims to allow a full-length trimeric Spike protein from the COVID-19 virus to be used as both a capture and detection tool
The agreement allows First Genetics to bring its F-Genetics NGS system and in vitro diagnostic assays for reproductive health testing to Russian labs
The partnership aims to bring access to Twist's proprietary phage display libraries for the discovery of antibodies in Takeda's biologics pipeline
Delivers major improvements for discoveries in immunology, oncology, autoimmunity, and infectious diseases
The strategic partnership aims to catapult COVID-19 diagnostic testing capacity well ahead of the significant demand
Starts Monday, July 6. Register for free today to stay informed on the latest techniques and technologies for COVID-19 and infectious disease research
Companies partner to integrate Abbott's FreeStyle Libre continuous glucose monitoring technology with Tandem's insulin delivery products to provide options to simplify and tailor diabetes management
The platform aims to deliver rapid and automated processing of human blood and blood products to obtain purified populations of immune cells
binx health’s proven molecular io platform combined with SHERLOCK CRISPR technology will enable rapid, accurate testing for SARS-CoV-2 in retail and near-patient settings
Only IgG assay from top four in vitro diagnostic manufacturers that detects antibodies targeting the receptor binding domain on the spike protein
Providing researchers with expanded capabilities in interrogating the tissue microenvironment
The partnership aims to provide accessible solutions for labs involved in COVID-19 testing
Intended for use by clinical laboratories and diagnostic manufacturers, the panel aims to evaluate SARS-CoV-2 antibody assays
Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier
The Oncomine Dx target test aims to identify HER2 gene mutations in non-small lung cancer patients
Clover Biopharmaceuticals initiates phase 1 study using GSK pandemic adjuvant in combination with COVID-19 vaccine candidate SCB-2019
Our new expert webinar series aims to help you get the most from your microbiology research
The company is providing well-characterized and standardized human primary cells with matching specialty cell culture media
Roche will access SpeeDx existing tests and technology to expand diagnostic products for the management of antibiotic resistance in STIs